{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["9(4)"],"submitter":["Al Hadidi S"],"funding":["NCI NIH HHS"],"journal":["Blood advances"],"pagination":["950-953"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11934280"],"repository":["biostudies-literature"],"pubmed_title":["Long-term follow-up of Total Therapy IV: a phase 3 clinical trial for standard-risk multiple myeloma."],"pmcid":["PMC11934280"],"funding_grant_id":["P01 CA055819"],"pubmed_authors":["Sawyer J","Bailey C","Schinke C","Barlogie B","Siegel ER","Al Hadidi S","Panozzo S","Thanendrarajan S","Shaughnessy J","Ababneh O","Smith R","Zangari M","Tricot G","Alapat D","Zhan F","van Rhee F"],"additional_accession":[]},"is_claimable":false,"name":"Long-term follow-up of Total Therapy IV: a phase 3 clinical trial for standard-risk multiple myeloma.","description":null,"dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Feb","modification":"2026-06-02T06:35:31.622Z","creation":"2026-04-15T03:15:35.64Z"},"accession":"S-EPMC11934280","cross_references":{"pubmed":["39786380"],"doi":["10.1182/bloodadvances.2024014889"]}}